ELLIPSE A/S: Financial statements 2023
CVR: 20560673
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
ELLIPSE A/S (CVR 20560673) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 1,300,672 and a net result of DKK -24,466,572 compared with DKK 1,121,861 the year before. Equity in the 2023 report amounted to DKK 40,227,789. The solvency ratio was 58.8%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 1,300,672
- Profit/Loss
- DKK -24,466,572
- Equity
- DKK 40,227,789
- Total Assets
- DKK 68,424,979
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 1.3M | -24.5M | 40.2M | 1 |
| 2022 | - | -421K | 1.1M | 64.7M | 1 |
| 2021 | - | 6.1M | 9.1M | 63.6M | 2 |
| 2020 | - | 12.9M | 3.9M | 148.5M | 35 |
| 2019 | - | 115.9M | 105.4M | 144.6M | 30 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
ELLIPSE A/S has published its annual report for 2022. Gross profit came to DKK -421,337, and the net result was DKK 1,121,861.
About ELLIPSE A/S
ELLIPSE A/S was a Danish company of the type Aktieselskab based in København Ø, founded in 1997. The company has been dissolved on 30 April 2025. The company was registered under the industry Fremstilling af bestrålingsudstyr og elektromedicinsk og elektroterapeutisk udstyr. The company was previously named 3D - DANISH DERMATOLOGIC DEVELOPMENT A/S. The company has 1 employee (2024). In 2023, the company reported a gross profit of DKK 1,300,672 and a net result of DKK -24,466,572 compared with DKK 1,121,861 the year before. Equity in the 2023 report amounted to DKK 40,227,789.